医学临床研究
醫學臨床研究
의학림상연구
JOURNAL OF CLINICAL RESEARCH
2015年
5期
866-867,871
,共3页
曲唑酮/治疗应用%阿普唑仑/治疗应用%卒中/并发症%入睡和睡眠障碍/病因学%入睡和睡眠障碍/药物疗法%急性病
麯唑酮/治療應用%阿普唑崙/治療應用%卒中/併髮癥%入睡和睡眠障礙/病因學%入睡和睡眠障礙/藥物療法%急性病
곡서동/치료응용%아보서륜/치료응용%졸중/병발증%입수화수면장애/병인학%입수화수면장애/약물요법%급성병
Trazodone/TU%Alprazolam/TU%Stroke/CO%Sleep Initiation and Maintenance Dis-orders/ET%Sleep Initiation and Maintenance Disorders/DT%Acute Disease
【目的】比较曲唑酮与阿普唑仑治疗首发脑卒中后急性失眠的临床效果。【方法】选择本院首发脑卒中后急性失眠患者173例,随机分为观察组90例和对照组83例;观察组应用曲唑酮片25~100mg/d,对照组应用阿普唑仑片0.4~0.8mg/d;分别记录两组在治疗前及治疗4周后阿森斯失眠量表(AIS)评分。【结果】治疗4周后AIS评分观察组(5.77±3.67)分较治疗前(16.78±3.32)分明显减少(P<0.05);且明显低于对照组治疗后(10.46±3.23)分(P<0.05);观察组治疗后总有效率为94.44%,明显高于对照组(81.93%)(χ2=6.62,P<0.05)。【结论】曲唑酮对首发脑卒中后急性失眠的治疗效果优于阿普唑仑。
【目的】比較麯唑酮與阿普唑崙治療首髮腦卒中後急性失眠的臨床效果。【方法】選擇本院首髮腦卒中後急性失眠患者173例,隨機分為觀察組90例和對照組83例;觀察組應用麯唑酮片25~100mg/d,對照組應用阿普唑崙片0.4~0.8mg/d;分彆記錄兩組在治療前及治療4週後阿森斯失眠量錶(AIS)評分。【結果】治療4週後AIS評分觀察組(5.77±3.67)分較治療前(16.78±3.32)分明顯減少(P<0.05);且明顯低于對照組治療後(10.46±3.23)分(P<0.05);觀察組治療後總有效率為94.44%,明顯高于對照組(81.93%)(χ2=6.62,P<0.05)。【結論】麯唑酮對首髮腦卒中後急性失眠的治療效果優于阿普唑崙。
【목적】비교곡서동여아보서륜치료수발뇌졸중후급성실면적림상효과。【방법】선택본원수발뇌졸중후급성실면환자173례,수궤분위관찰조90례화대조조83례;관찰조응용곡서동편25~100mg/d,대조조응용아보서륜편0.4~0.8mg/d;분별기록량조재치료전급치료4주후아삼사실면량표(AIS)평분。【결과】치료4주후AIS평분관찰조(5.77±3.67)분교치료전(16.78±3.32)분명현감소(P<0.05);차명현저우대조조치료후(10.46±3.23)분(P<0.05);관찰조치료후총유효솔위94.44%,명현고우대조조(81.93%)(χ2=6.62,P<0.05)。【결론】곡서동대수발뇌졸중후급성실면적치료효과우우아보서륜。
[Objective]To compare the curative effects of two methods in treating post‐stroke acute insomnia .[Methods] A total of 173 patients with acute post‐stroke insomnia were randomly divided into observation ( n=90) and control ( n=83) groups .The control group received alprazolam 0 .4~0 .8 mg/day while the observation group took trazodone hydrochloride 25~100 mg/day .The AIS score before treatment and during a 4‐week follow‐up were observed .[Results] After treatment ,the Athens insomnia scale (AIS) score of observation group was (5 .77 ± 3 .67) versus(16 .78 ± 3 .32)before treatment .And the difference in AIS score before and after treatment was significant ( P<0 .05) .After treatment ,the AIS score of observation group was significantly lower than that of control group (5 . 77 ± 3 .67 vs 10 .46 ± 3 .23 ,P<0 .05) .The clinical efficacy rate was 94 .44% in observation group and it was obvi‐ously higher than 81 .93% in control group(χ2 =6 .62 ,P<0 .05) .[Conclusion] Trazodone hydrochloride is superior to alprazolam in the treatment of post‐stroke insomnia .